Side effects or complications-Motor fluctuations Posts on Medivizor
Navigation Menu

Side effects or complications-Motor fluctuations Posts on Medivizor

Evaluating the effectiveness and safety of continuous subcutaneous foslevodopa-foscarbidopa for the treatment of motor fluctuations in patients with Parkinson’s disease.

Evaluating the effectiveness and safety of continuous subcutaneous foslevodopa-foscarbidopa for the treatment of motor fluctuations in patients with Parkinson’s disease.

Posted by on Sep 17, 2023 in Parkinson's Disease | 0 comments

In a nutshell This study evaluated the effectiveness and safety of continuous subcutaneous foslevodopa-foscarbidopa (ABBV-951) for the treatment of motor fluctuations in patients with Parkinson’s disease (PD). The data showed that continuous subcutaneous foslevodopa-foscarbidopa significantly improved motor fluctuations in these patients. Some...

Read More

Is AADC gene therapy a valuable option for patients with moderately advanced Parkinson Disease?

Is AADC gene therapy a valuable option for patients with moderately advanced Parkinson Disease?

Posted by on Dec 31, 2021 in Parkinson's Disease | 0 comments

In a nutshell In this work, the authors studied whether VY-AADC01 (NBIb-1817) gene therapy was safe and effective in patients with moderately advanced Parkinson's disease (PD) patients with motor fluctuations. The authors showed that this treatment caused an improvement in motor function, quality of life, and a decrease in the level of...

Read More

Helicobacter pylori treatment improves symptoms in patients with advanced Parkinson’s disease

Helicobacter pylori treatment improves symptoms in patients with advanced Parkinson’s disease

Posted by on Jun 6, 2021 in Parkinson's Disease | 0 comments

In a nutshell This study investigated how Helicobacter pylori (HP) infection and its treatment affect the treatment of Parkinson’s disease (PD). Researchers suggested that HP treatment improves the symptoms of patients with PD. Some background PD commonly affects older people. It affects the brain cells causing symptoms such...

Read More

Extended-release levodopa treatment increases the ON time of patients with Parkinson’s disease

Extended-release levodopa treatment increases the ON time of patients with Parkinson’s disease

Posted by on Feb 21, 2021 in Parkinson's Disease | 0 comments

In a nutshell This study investigated the duration of ON time in patients with Parkinson’s disease treated with levodopa-carbidopa (LD-CD). Researchers suggested that LD-CL extended-release (ER) capsules (Rytary) increased ON time in these patients. Some background Parkinson’s disease affects brain cells. These cells lose their ability to...

Read More

CVT-301 inhaled levodopa is as safe as standard levodopa in patients with Parkinson’s disease and off-symptoms

Posted by on Feb 21, 2020 in Parkinson's Disease | 0 comments

In a nutshell This study investigated the safety and effectiveness of CVT-301 (Inbrija) for the treatment of wearing-off symptoms in patients with Parkinson's disease. Researchers suggested that this treatment was effective in improving off periods with no significant differences in side effects compared to standard levodopa. Some background...

Read More

Sublingual apomorphine is a safe and effective treatment for off episodes in patients with Parkinson’s disease

Posted by on Dec 31, 2019 in Parkinson's Disease | 0 comments

In a nutshell This study investigated the effectiveness of sublingual apomorphine (Apokyn) in the treatment of off times in patients with Parkinson's disease. Researchers suggested that this treatment might be a safe and effective option for the treatment of these patients. Some background Parkinson's disease (PD) is the second most...

Read More

Accordion pill (carbidopa-levodopa) is associated with reduced motor fluctuations in patients with Parkinson’s disease

Posted by on Jun 30, 2019 in Parkinson's Disease | 0 comments

In a nutshell This study investigated the effectiveness of a new carbidopa–levodopa treatment for patients with Parkinson's disease. Researchers suggested that this treatment is associated with a better control of the symptoms. Some background Nearly one million people will have Parkinson's disease (PD) in the US by 2020. This disease...

Read More

Gocovri treatment decreases dyskinesia and off times in patients with Parkinson’s disease

Posted by on Jun 16, 2019 in Parkinson's Disease | 0 comments

In a nutshell This study investigated the effectiveness of Gocovri (amantadine) in the treatment of dyskinesia (DYS) in patients with Parkinson's disease (PD). Researchers suggested that this treatment improves DYS symptoms. Some background PD affects brain cells. The abilities controlled by these cells are lost, such as muscle function and...

Read More

Increasing carbidopa dose together with levodopa, and entacapone treatment improves the outcomes in Parkinson’s disease

Posted by on Mar 29, 2019 in Parkinson's Disease | 0 comments

In a nutshell This study investigated whether increasing the doses of carbidopa/levodopa treatment improves the outcomes of patients with Parkinson's disease. Researchers suggested that higher doses of carbidopa together with levodopa and entacapone should be considered as an option for the treatment of patients with Parkinson's disease. Some...

Read More

Repetitive transcranial magnetic stimulation to treat Parkinson´s symptoms

Posted by on Jul 23, 2018 in Parkinson's Disease | 0 comments

In a nutshell This study investigated the effectiveness of repetitive transcranial magnetic stimulation (rTMS) at controlling the symptoms of Parkinson´s patients. Researchers suggested that rTMS reduced the symptoms of these patients.   Some background Parkinson’s is a progressive disease. Medications are the main treatment option,...

Read More